Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
24 Oct 2023
Historique:
medline: 1 11 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Integrin-dependent adhesion to the extracellular matrix (ECM) mediates mechanosensing and signaling in response to altered microenvironmental conditions. In order to provide tissue- and organ-specific cues, the ECM is composed of many different proteins that temper the mechanical properties and provide the necessary structural diversity. Despite most human tissues being soft, the prevailing view from predominantly in vitro studies is that increased stiffness triggers effective cell spreading and activation of mechanosensitive signaling pathways. To address the functional coupling of ECM composition and matrix rigidity on compliant substrates, we developed a matrix spot array system to screen cell phenotypes against different ECM mixtures on defined substrate stiffnesses at high resolution. We applied this system to both cancer and normal cells and surprisingly identified ECM mixtures that support stiffness-insensitive cell spreading on soft substrates. Employing the motor-clutch model to simulate cell adhesion on biochemically distinct soft substrates, with varying numbers of available ECM-integrin-cytoskeleton (clutch) connections, we identified conditions in which spreading would be supported on soft matrices. Combining simulations and experiments, we show that cell spreading on soft is supported by increased clutch engagement on specific ECM mixtures and even augmented by the partial inhibition of actomyosin contractility. Thus, "stiff-like" spreading on soft is determined by a balance of a cell's contractile and adhesive machinery. This provides a fundamental perspective for in vitro mechanobiology studies, identifying a mechanism through which cells spread, function, and signal effectively on soft substrates.

Identifiants

pubmed: 37844244
doi: 10.1073/pnas.2304288120
pmc: PMC10614832
doi:

Substances chimiques

Integrins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2304288120

Subventions

Organisme : Academy of Finland (AKA)
ID : 325464
Organisme : Academy of Finland (AKA)
ID : 346131
Organisme : Academy of Finland (AKA)
ID : 337530
Organisme : Academy of Finland (AKA)
ID : 332402
Organisme : Academy of Finland (AKA)
ID : 338585
Organisme : EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA)
ID : 841973
Organisme : SKR | Varsinais-Suomen Rahasto (Varsinais-Suomi Regional Fund)
ID : 00210428

Références

Biophys J. 2013 Aug 6;105(3):581-92
pubmed: 23931306
Nat Rev Cancer. 2014 May;14(5):314-28
pubmed: 24739578
J Clin Oncol. 2010 Oct 1;28(28):4316-23
pubmed: 20805453
Front Cell Dev Biol. 2021 Dec 01;9:755406
pubmed: 34926447
Nat Protoc. 2018 Jan;13(1):155-169
pubmed: 29266096
Matrix Biol Plus. 2019 Apr 06;1:100004
pubmed: 33543003
J Biol Chem. 2001 Dec 21;276(51):48206-12
pubmed: 11572855
J Cell Sci. 2009 Nov 15;122(Pt 22):4009-11
pubmed: 19910492
IET Syst Biol. 2008 Jan;2(1):8-15
pubmed: 18248081
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3872-81
pubmed: 27317747
Science. 2009 Jan 30;323(5914):642-4
pubmed: 19179533
Nat Cell Biol. 2013 Jun;15(6):625-36
pubmed: 23708002
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Clin Cancer Res. 1995 Sep;1(9):1035-41
pubmed: 9816077
J Cell Sci. 2020 Jun 22;133(12):
pubmed: 32393601
Oncotarget. 2015 Nov 3;6(34):36762-73
pubmed: 26447611
Integr Biol (Camb). 2015 Oct;7(10):1120-34
pubmed: 25959051
Nat Methods. 2005 Feb;2(2):119-25
pubmed: 15782209
Nature. 2012 Jul 26;487(7408):500-4
pubmed: 22763439
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43
pubmed: 15701700
Nat Mater. 2014 Jun;13(6):631-7
pubmed: 24793358
PLoS One. 2011;6(5):e18640
pubmed: 21611158
J Cell Biol. 2002 Nov 25;159(4):695-705
pubmed: 12446745
Cell. 2017 Nov 30;171(6):1397-1410.e14
pubmed: 29107331
Sci Adv. 2021 Oct;7(40):eabh0363
pubmed: 34586840
J Cell Sci. 2012 Feb 1;125(Pt 3):649-61
pubmed: 22389402
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188356
pubmed: 32147542
Cell. 2013 Aug 29;154(5):1047-1059
pubmed: 23954413
Nat Commun. 2012;3:1122
pubmed: 23047680
Nat Rev Mol Cell Biol. 2017 Dec;18(12):758-770
pubmed: 28951564
Nat Commun. 2017 May 22;8:15313
pubmed: 28530245
Nat Biomed Eng. 2023 Feb;7(2):177-191
pubmed: 35996026
Essays Biochem. 2019 Oct 31;63(5):535-551
pubmed: 31444228
Nat Med. 2008 May;14(5):518-27
pubmed: 18438415
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
J Exp Med. 2021 May 3;218(5):
pubmed: 33822843
Nat Med. 2017 Jul;23(7):890-898
pubmed: 28604702
Nat Commun. 2022 Aug 6;13(1):4587
pubmed: 35933466
Sci Rep. 2019 Jul 18;9(1):10460
pubmed: 31320676
J Clin Invest. 2001 May;107(9):1063-9
pubmed: 11342567
Nat Commun. 2015 Dec 04;6:10038
pubmed: 26634421
Small GTPases. 2014;5:e27958
pubmed: 24607953
Sci Adv. 2022 Mar 25;8(12):eabl3667
pubmed: 35319996
Nat Methods. 2011 May;8(5):424-9
pubmed: 21478862
Histopathology. 2014 Mar;64(4):512-22
pubmed: 24117661
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Mol Biol Cell. 2021 Jun 15;32(13):1221-1228
pubmed: 33909446
Nat Methods. 2017 Jan;14(1):53-56
pubmed: 27869816
Nat Rev Mol Cell Biol. 2016 Aug;17(8):496-510
pubmed: 27301673
Nat Commun. 2016 Aug 04;7:12237
pubmed: 27488962
Acta Biomater. 2022 Jan 15;138:240-253
pubmed: 34800715
J Cell Biol. 2001 Apr 16;153(2):273-82
pubmed: 11309409
Nat Mater. 2022 Mar;21(3):366-377
pubmed: 34663953
Elife. 2021 Dec 02;10:
pubmed: 34854380
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3091-100
pubmed: 25024225
Sci Signal. 2013 Jul 23;6(285):rs12
pubmed: 23882122
Curr Top Membr. 2015;76:197-229
pubmed: 26610915
Dev Cell. 2015 Oct 12;35(1):78-92
pubmed: 26439400
Science. 2008 Dec 12;322(5908):1687-91
pubmed: 19074349
Dev Biol. 2001 Sep 1;237(1):116-29
pubmed: 11518510
Nature. 2009 Sep 3;461(7260):99-103
pubmed: 19693013
iScience. 2020 Mar 27;23(3):100907
pubmed: 32106057
Sci Adv. 2020 Oct 21;6(43):
pubmed: 33087348
Curr Opin Cell Biol. 2019 Feb;56:64-70
pubmed: 30292078
Dev Cell. 2023 Mar 27;58(6):522-534.e7
pubmed: 36924770
Nat Rev Genet. 2009 Mar;10(3):173-83
pubmed: 19204719
Nat Mater. 2022 Sep;21(9):1081-1090
pubmed: 35817964
Nat Cell Biol. 2016 May;18(5):540-8
pubmed: 27065098

Auteurs

James R W Conway (JRW)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.

Aleksi Isomursu (A)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.

Gautier Follain (G)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.

Ville Härmä (V)

Misvik Biology Oy, Turku FI-20520, Finland.
Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, United Kingdom.

Eva Jou-Ollé (E)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.

Nicolas Pasquier (N)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.

Eetu P O Välimäki (EPO)

Misvik Biology Oy, Turku FI-20520, Finland.

Juha K Rantala (JK)

Misvik Biology Oy, Turku FI-20520, Finland.
Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, United Kingdom.

Johanna Ivaska (J)

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.
Department of Life Technologies, University of Turku, Turku FI-20520, Finland.
InFLAMES Research Flagship, University of Turku, Turku FI-20520, Finland.
Western Finnish Cancer Center, University of Turku, Turku FI-20520, Finland.
Foundation for the Finnish Cancer Institute, Helsinki FI-00014, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH